A cost analysis study of the implementation of fixed-dosing of monoclonal antibodies in the Netherlands Cancer Institute von Heinhuis, Kimberley M., Barkman, Hannerieke J., Beijnen, Jos H., Hendrikx, Jeroen J. M. A.

Volltext

Redispensing of expensive oral anticancer medicines: A practical application von Akgöl, Kübra, van Merendonk, Lisanne N, Barkman, Hannerieke J, van Balen, Dorieke EM, van den Hoek, Hester L, Klous, Marjolein G, Hendrikx, Jeroen JMA, Huitema, Alwin DR, Beijnen, Jos H, Nuijen, Bastiaan

Volltext

Clinical Relevance of High Plasma Trough Levels of the Kinase Inhibitors Crizotinib, Alectinib, Osimertinib, Dabrafenib, and Trametinib in NSCLC Patients von Lin, Lishi, Barkman, Hannerieke J, Smit, Egbert F, De Langen, Adrianus J, Steeghs, Neeltje, Beijnen, Jos H, Huitema, Alwin D.R

Volltext